BlackRock has announced the upcoming liquidation of several U.S.-domiciled mutual funds and ETFs, including the BlackRock Health Sciences Trust, as part of its ongoing assessment to meet investors' evolving needs. The liquidation process involves 14 funds in total, with specific liquidation dates provided for each. Investors in these funds will continue to incur management fees until the liquidations are finalized, and those opting to sell their ETFs will also bear transaction and commission costs. This move is part of BlackRock's broader strategy to align its investment offerings with client objectives, leveraging its expansive platform to manage over $1 trillion in sustainable and transition investing assets globally.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blackrock Health Sciences Trust published the original content used to generate this news brief via Business Wire (Ref. ID: 20250613921212) on June 13, 2025, and is solely responsible for the information contained therein.